X
27Apr

[Video] Six Things You Need to Know About Life Sciences M&A During and After COVID-19

While life sciences M&A activity soared to a new high in 2019, the uncertainty surrounding the pandemic has led to a slow down in deal making activity. However, as the crisis in the U.S. subsides and the U.S. economy stabilizes, we expect life...
By: Arnall Golden Gregory LLP
Source Url: https://www.jdsupra.com/legalnews/six-things-you-need-to-know-about-life-s-95385/

Related

PFI: benchmarking and market testing, a cause of conflict in the long run?

The ongoing Scottish case of Serco Limited v Forth Health Limited highlights the difficulties that c...

Read More >

FDA Clarifies Premarket Path for Ecigarette Products

The US Food and Drug Administration (FDA or the Agency) on June 11 issued the final guidance: “Prem...

Read More >

Federal Motor Carrier Safety Agency Proposes Changes To Hours Of Service Rules For Truck Drivers

The U.S. Department of Transportation’s Federal Motor Carrier Safety Administration (FMCSA) has pub...

Read More >

Paycheck Protection Program – Loan Forgiveness

From the initial real estate purchase to completing construction, the entire real estate industry ha...

Read More >

DOL Issues Final Rule on Salary Requirements for Exempt Employees

As expected, the US Department of Labor issued a new final rule on FLSA overtime exemptions this wee...

Read More >

Managing a Multi-National Workforce: Sponsorship Agreements, Retention Policies and Liquidated Damages

In our ever-increasing multi-multinational workforce that seems to rely more heavily on foreign labo...

Read More >